Bronchoscopic interventions for severe emphysema: Where are we now?

Pallav L Shah*, Dirk-Jan Slebos

*Corresponding author voor dit werk

Onderzoeksoutput: Review articlepeer review

21 Citaten (Scopus)
163 Downloads (Pure)

Samenvatting

Patients with severe emphysema have limited treatment options and only derive a small benefit from optimal medical treatment. The only other therapy to have significant clinical beneficial effect in emphysema is LVRS but the perceived risk and invasiveness of surgery has fuelled bronchoscopic approaches to induce lung volume reduction. There are multiple bronchoscopic methods for achieving volume reduction in severe emphysema: EBV, airway bypass procedure, endobronchial coils, thermal (vapour) sclerosis and chemical sclerosis (sealants). Optimal patient selection is key to successful patient outcomes. This review discusses bronchoscopic approaches for emphysema treatment which has progressed through clinical trials to clinical practice.

Originele taal-2English
Pagina's (van-tot)972-980
Aantal pagina's9
TijdschriftRespirology
Volume25
Nummer van het tijdschrift9
Vroegere onlinedatum3-mei-2020
DOI's
StatusPublished - sep.-2020

Vingerafdruk

Duik in de onderzoeksthema's van 'Bronchoscopic interventions for severe emphysema: Where are we now?'. Samen vormen ze een unieke vingerafdruk.

Citeer dit